Latest Breaking News On - Roche venture fund - Page 3 : comparemela.com

Cour Pharmaceuticals Closes Approximately $105M Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United statesBenjamin beni rovinskiSimon greenwoodJohnj puisisPfizer breakthrough growth initiativeBristol myers squibbIronwood pharmaceuticalsRd fundCour pharmaceuticalsRoche venture fundTakeda pharmaceuticalsLumira venturesAlpha wave venturesAngelini venturesManaging directorSenior investment director

Update on Regulatory Review of leriglitazone in the EU

Update on Regulatory Review of leriglitazone in the EU

Comunidad autonoma de catalunaUnited statesMarc martinellLaboratorios lesviMichelle boxallThomas dierksImage box communicationsStrategic communicationsNeuraxpharm pharmaceuticalsNeuraxpharm groupCommittee for medicinal products human useRoche venture fundMinoryx therapeuticsMedicinal productsHuman useHematopoietic stem cell transplantation

Enthera Pharmaceuticals Appoints Lisa M Olson as CEO and Announces Clinical Trial Progress with Ent001

Enthera Pharmaceuticals Appoints Lisa M Olson as CEO and Announces Clinical Trial Progress with Ent001
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Lisam olsonEnthera srlStefan klotterSilvano spinelliFrancesca daddioPaolo fiorinaPfizer incSite head of the abbvie bioresearch centerResearch fellow in inflammationEnthera pharmaceuticalsIowa state universityTrophic communicationsRd fundRoche venture fundAbbott laboratoriesUniversity of illinois at urbana champaign

F Hoffmann-La Roche Ltd Digital Transformation Strategy Analysis Report 2023: Technology Focus, Initiatives, Roche Venture Fund, Investments, Acquisitions, Partnerships, ICT Budget and Contracts

/PRNewswire/ The "F. Hoffmann-La Roche Ltd - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com s offering. This.

United kingdomLaura woodE st office hours callGe healthcareRoche ltdOffice hours callNovo nordiskInvestment networkFlatiron healthSensyne healthAlan turing instituteRoche venture fundHoffmann la roche ltdTopics coveredRoche ventureFree call

GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer

/PRNewswire/ GlycoEra AG, a pioneering company advancing a pipeline of extracellular protein degraders for the treatment of autoimmune disorders, today.

Greg fralishGanesh kaundinyaBristol myers squibbHead of corporate developmentNational resilienceRoche venture fundTakeda head of oncology business developmentOncology corporate developmentNovo nordiskSofinnova partnersChief business officerChief executive officerVice presidentCorporate developmentOncology businessGlycoera ag